Skip to main content

Immune Deficiency Foundation

..

immunocompromised collaborative logo
Donate
  • Taking Action
  • Other News
  • Meet Our Steering Committee
  • Contact Us

Other News

Featured news related to the immunocompromised community.

You are here

Home

COVID-19 Public Health Emergency renewed for 90 days

4/12/22

Sotrovimab no longer authorized in U.S. due to rise of Omicron sub-variant BA.2

4/5/22

ASPR launches COVID-19 Test to Treat locator tool

3/31/22

Researchers announce use of COVID-19 vaccine to treat chronic SARS-CoV-2 infection

3/21/22

Congress extends pandemic telehealth flexibilities in FY 2022 spending bill

3/15/22

CDC announces new metrics for gauging COVID-19 risk and guiding mitigation strategies like masking

2/25/22

FDA doubles recommended dose of Evusheld for COVID-19 prevention

2/24/22

Federal government purchases additional doses of COVID-19 preventative Evusheld

2/14/22

FDA authorizes monoclonal antibody bebtelovimab for treatment of COVID-19 in high-risk patients

2/11/22

CDC recommends COVID-19 booster three months from primary mRNA vaccine series for immunocompromised

2/11/22

US FDA amends authorizations for an additional COVID-19 mRNA vaccine dose for immunocompromised

8/13/21

 

Immunocompromised Collaborative Steering Committee Members:

  • The Aids Institute is a Sponsor
  • Autoimmune Association is a Sponsor
  • IDF is a Sponsor
  • The Lupus Foundation is a Sponsor
  • Susan G Komen is a Sponsor

 

410-321-6647

idf@primaryimmune.org

An initiative of the Immune Deficiency Foundation, a 501 (c)(3) organization (EIN: 52-1214782)